News | May 11, 2015

Twelve Late-Breaking Clinical Trials to be Presented at Heart Rhythm 2015

Key studies that will help advance electrophysiology at HRS

May 11, 2015 — The Heart Rhythm Society (HRS) has released the list of its 12 late-breaking electrophysiology (EP) clinical trials that will be presented at Heart Rhythm 2015, which takes place May 13-16, 2015 in Boston. 
 
Session I: Thursday, May 14, 1:30– 3 p.m. EDT in Ballroom West?
Impact of Remote Monitoring on Clinical Events and Healthcare Utilization: A nationwide assessment
VENTURE-AF: A Randomized Global Trial Evaluating Uninterrupted Rivaroxaban and Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Nonvalvular Atrial Fibrillation
Cryoballoon Versus Open Irrigated Radiofrequency Ablation in Patients with Paroxysmal Atrial Fibrillation: The prospective, randomized controlled, non-inferiority FreezeAF Study
Botulinum Toxin Injection in Epicardial Fat Pads for Prevention of Atrial Fibrillation After Cardiac Surgery: One year follow up of randomized pilot study
Wireless LV Endocardial Stimulation for CRT: Primary results of the Safety and Performance of Electrodes implanted in the Left Ventricle (SELECT-LV) Study
The Evera MRI Study
 
Session II: Friday, May 15, 2015, 8–9:30 a.m. EDT in Ballroom West?
Performance of a Miniaturized Transcatheter Pacing System: First-in-human experience
Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Chronic Resynchronization Therapy
Canadian Registry of Cardiac Implantable Electronic Device Outcomes: Phase 1 Riata Lead on Advisory (CREDO)
Clinical Safety of the Iforia ProMRI ICD System Subjected to 1.5T Cardiac or Thoracic Spine MRI
Effect of linear ablation in substrate-based AF: Results of the Substrate Modification with Ablation and Antiarrhythmic Drugs in Nonpermanent Atrial Fibrillation trial
Visually-Guided Laser Balloon (VGLB) Pulmonary Vein Isolation For The Treatment of Paroxysmal Atrial Fibrillation (PAF): Results Of The Prospective Multicenter Randomized Heartlight Study 
 
For more information: www.HRSonline.org
?
 

Related Content

Abbott Announces European Launch of Advisor HD Grid Mapping Catheter, Sensor Enabled
Technology | EP Mapping and Imaging Systems | January 19, 2018
Abbott last week announced CE Mark approval for the company's new Advisor HD Grid Mapping Catheter, Sensor Enabled, a...
Videos | EP Mapping and Imaging Systems | October 24, 2017
This video, provided by Acutus Medical, demonstrates a patient case showing the use of the AcQMap high-resolution ele
Acutus Medical Receives FDA Clearance for AcQMap Cardiac Mapping Technology
Technology | EP Mapping and Imaging Systems | October 24, 2017
Acutus Medical announced that the U.S. Food and Drug Administration (FDA) has cleared the AcQMap High Resolution...
Acutus Medical Announces Completion of Enrollment for UNCOVER AF Study
News | EP Mapping and Imaging Systems | May 02, 2017
Acutus Medical recently announced that enrollment has been completed in its pivotal Utilizing Novel Dipole Density...
Videos | EP Mapping and Imaging Systems | February 01, 2017
This video, provided by Medtronic, demonstrates the CardioInsight electro-anatomical mapping system.
medtronic cardioinsight electromapping system, electoanatomical mapping, noninvasive ep mapping

A screen shot of the waveforms and the the 3-D electo-mapping models created using the noninvasive CardioInsight system.

Technology | EP Mapping and Imaging Systems | February 01, 2017
February 1, 2017 — Medtronic received U.S.
BioSig Technologies, Pure EP system, JACC Clinical Electrophysiology, Journal of the American College of Cardiology, Purkinje Network
News | EP Mapping and Imaging Systems | January 16, 2017
January 16, 2017 — BioSig Technologies Inc. announced that the company’s Pure EP System, a novel cardiac...
St. Jude Medical, EnSite Precision cardiac mapping system, FDA clearance, catheter ablation
Technology | EP Mapping and Imaging Systems | January 03, 2017
St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) clearance of its EnSite Precision™ cardiac...
Acutus Medical, AcQMap High Resolution Imaging and Mapping System, atrial fibrillation, UNCOVER-AF trial, first procedure
News | EP Mapping and Imaging Systems | October 27, 2016
Acutus Medical announced the completion of the first patient procedure in the “Utilizing Novel Dipole Density...
St. Jude Medical, Ensite Precision cardiac mapping system, full European market release
News | EP Mapping and Imaging Systems | October 06, 2016
St. Jude Medical Inc. announced a full market release of its EnSite Precision cardiac mapping system and new Sensor...
Overlay Init